Author: Rishabha Malviya
Publisher: CRC Press
ISBN: 100096518X
Category : Business & Economics
Languages : en
Pages : 423
Book Description
The pharmaceutical industry is on the cusp of a new age, with the need for personalized therapy, more complex production processes, smaller batch sizes and rising manufacturing costs. It is necessary to continuously adapt to the rapidly changing environment using novel technology and improved operational efficiency and flexibility. To achieve this, intelligent manufacturing seems to be a definite answer. Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. This book provides a deep insight into key technologies that will modernize pharmaceutical manufacturing and facilitate digital transformation. Throughout the book we discuss technologies, application and challenges for applying digital technology in pharmaceutical industry, including: • Focus on an overview of Industry 4.0 and its application in the pharmaceutical field • Most recent advances in the pharmaceutical industry • Understanding the concepts of emerging technology trends for drug discovery.
Pharmaceutical industry 4.0: Future, Challenges & Application
Competitive Problems in the Drug Industry
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 712
Book Description
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 712
Book Description
The Fourth Industrial Revolution
Author: Klaus Schwab
Publisher: Crown Currency
ISBN: 1524758876
Category : Business & Economics
Languages : en
Pages : 194
Book Description
World-renowned economist Klaus Schwab, Founder and Executive Chairman of the World Economic Forum, explains that we have an opportunity to shape the fourth industrial revolution, which will fundamentally alter how we live and work. Schwab argues that this revolution is different in scale, scope and complexity from any that have come before. Characterized by a range of new technologies that are fusing the physical, digital and biological worlds, the developments are affecting all disciplines, economies, industries and governments, and even challenging ideas about what it means to be human. Artificial intelligence is already all around us, from supercomputers, drones and virtual assistants to 3D printing, DNA sequencing, smart thermostats, wearable sensors and microchips smaller than a grain of sand. But this is just the beginning: nanomaterials 200 times stronger than steel and a million times thinner than a strand of hair and the first transplant of a 3D printed liver are already in development. Imagine “smart factories” in which global systems of manufacturing are coordinated virtually, or implantable mobile phones made of biosynthetic materials. The fourth industrial revolution, says Schwab, is more significant, and its ramifications more profound, than in any prior period of human history. He outlines the key technologies driving this revolution and discusses the major impacts expected on government, business, civil society and individuals. Schwab also offers bold ideas on how to harness these changes and shape a better future—one in which technology empowers people rather than replaces them; progress serves society rather than disrupts it; and in which innovators respect moral and ethical boundaries rather than cross them. We all have the opportunity to contribute to developing new frameworks that advance progress.
Publisher: Crown Currency
ISBN: 1524758876
Category : Business & Economics
Languages : en
Pages : 194
Book Description
World-renowned economist Klaus Schwab, Founder and Executive Chairman of the World Economic Forum, explains that we have an opportunity to shape the fourth industrial revolution, which will fundamentally alter how we live and work. Schwab argues that this revolution is different in scale, scope and complexity from any that have come before. Characterized by a range of new technologies that are fusing the physical, digital and biological worlds, the developments are affecting all disciplines, economies, industries and governments, and even challenging ideas about what it means to be human. Artificial intelligence is already all around us, from supercomputers, drones and virtual assistants to 3D printing, DNA sequencing, smart thermostats, wearable sensors and microchips smaller than a grain of sand. But this is just the beginning: nanomaterials 200 times stronger than steel and a million times thinner than a strand of hair and the first transplant of a 3D printed liver are already in development. Imagine “smart factories” in which global systems of manufacturing are coordinated virtually, or implantable mobile phones made of biosynthetic materials. The fourth industrial revolution, says Schwab, is more significant, and its ramifications more profound, than in any prior period of human history. He outlines the key technologies driving this revolution and discusses the major impacts expected on government, business, civil society and individuals. Schwab also offers bold ideas on how to harness these changes and shape a better future—one in which technology empowers people rather than replaces them; progress serves society rather than disrupts it; and in which innovators respect moral and ethical boundaries rather than cross them. We all have the opportunity to contribute to developing new frameworks that advance progress.
Digital Transformation in Healthcare 5.0
Author: Rishabha Malviya
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 311132785X
Category : Computers
Languages : en
Pages : 348
Book Description
"Digital Transformation in Healthcare 5.0: IoT, AI, and Digital Twin" provides a comprehensive overview of the integration of cutting-edge technology with healthcare, from the Fourth Industrial Revolution (4IR) to the introduction of IoT, AI, and Digital Twin technologies. This in-depth discussion of the digital revolution expanding the healthcare industry covers a wide range of topics, including digital disruption in healthcare delivery, the impact of 4IR and Health 4.0, e-health services and applications, virtual reality's impact on accessible healthcare delivery, digital twins and dietary health technologies, big data analytics in healthcare systems, machine learning models for cost-effective healthcare delivery systems, affordable healthcare with machine learning, enhanced biomedical signal processing with machine learning, and data-driven AI for information retrieval of biomedical images.
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 311132785X
Category : Computers
Languages : en
Pages : 348
Book Description
"Digital Transformation in Healthcare 5.0: IoT, AI, and Digital Twin" provides a comprehensive overview of the integration of cutting-edge technology with healthcare, from the Fourth Industrial Revolution (4IR) to the introduction of IoT, AI, and Digital Twin technologies. This in-depth discussion of the digital revolution expanding the healthcare industry covers a wide range of topics, including digital disruption in healthcare delivery, the impact of 4IR and Health 4.0, e-health services and applications, virtual reality's impact on accessible healthcare delivery, digital twins and dietary health technologies, big data analytics in healthcare systems, machine learning models for cost-effective healthcare delivery systems, affordable healthcare with machine learning, enhanced biomedical signal processing with machine learning, and data-driven AI for information retrieval of biomedical images.
3D Printing of Pharmaceuticals
Author: Abdul W. Basit
Publisher: Springer
ISBN: 3319907557
Category : Medical
Languages : en
Pages : 246
Book Description
3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.
Publisher: Springer
ISBN: 3319907557
Category : Medical
Languages : en
Pages : 246
Book Description
3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.
Artificial Intelligence for Health 4.0: Challenges and Applications
Author: Rishabha Malviya
Publisher: CRC Press
ISBN: 1000847020
Category : Computers
Languages : en
Pages : 420
Book Description
Healthcare is one of the major success stories of our times. Medical science has improved rapidly, raising life expectancy around the world. However, as longevity increases, healthcare systems face growing demands for their services, rising costs, and a workforce that is struggling to meet the needs of its patients. Healthcare is one of the most critical sectors in the broader landscape of big data because of its fundamental role in a productive, thriving society. Building on automation, artificial intelligence (AI) has the potential to revolutionize healthcare and help address some of the challenges set out above. The application of AI to healthcare data can literally be a matter of life and death. AI can assist doctors, nurses, and other healthcare workers in their daily work. AI in healthcare can enhance preventive care and quality of life, produce more accurate diagnoses and treatment plans, and lead to better patient outcomes overall. This book gives insights into the latest developments of applications of AI in biomedicine, including disease diagnostics, pharmaceutical processing, patient care and monitoring, biomedical information, and biomedical research. It also presents an outline of the recent breakthroughs in the application of AI in healthcare, describes a roadmap to building effective, reliable, and safe AI systems, and discusses the possible future direction of AI augmented healthcare systems. AI has countless applications in healthcare. Whether it’s being used to discover links between genetic codes, to power surgical robots or even to maximize hospital efficiency; AI has been a boon to the healthcare industry.
Publisher: CRC Press
ISBN: 1000847020
Category : Computers
Languages : en
Pages : 420
Book Description
Healthcare is one of the major success stories of our times. Medical science has improved rapidly, raising life expectancy around the world. However, as longevity increases, healthcare systems face growing demands for their services, rising costs, and a workforce that is struggling to meet the needs of its patients. Healthcare is one of the most critical sectors in the broader landscape of big data because of its fundamental role in a productive, thriving society. Building on automation, artificial intelligence (AI) has the potential to revolutionize healthcare and help address some of the challenges set out above. The application of AI to healthcare data can literally be a matter of life and death. AI can assist doctors, nurses, and other healthcare workers in their daily work. AI in healthcare can enhance preventive care and quality of life, produce more accurate diagnoses and treatment plans, and lead to better patient outcomes overall. This book gives insights into the latest developments of applications of AI in biomedicine, including disease diagnostics, pharmaceutical processing, patient care and monitoring, biomedical information, and biomedical research. It also presents an outline of the recent breakthroughs in the application of AI in healthcare, describes a roadmap to building effective, reliable, and safe AI systems, and discusses the possible future direction of AI augmented healthcare systems. AI has countless applications in healthcare. Whether it’s being used to discover links between genetic codes, to power surgical robots or even to maximize hospital efficiency; AI has been a boon to the healthcare industry.
Leading Pharmaceutical Innovation
Author: Oliver Gassmann
Publisher: Springer Science & Business Media
ISBN: 3540247815
Category : Business & Economics
Languages : en
Pages : 184
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Publisher: Springer Science & Business Media
ISBN: 3540247815
Category : Business & Economics
Languages : en
Pages : 184
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Research and Development in the Pharmaceutical Industry (A CBO Study)
Author: Congressional Budget Office
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Emergence of Pharmaceutical Industry Growth with Industrial IoT Approach
Author: Valentina Emilia Balas
Publisher: Academic Press
ISBN: 0128203668
Category : Medical
Languages : en
Pages : 356
Book Description
Emergence of Pharmaceutical Industry Growth with Industrial IoT Approach uses an innovative approach to explore how the Internet of Things (IoT) and big data can improve approaches, create efficiencies and make discoveries. Rapid growth of the IoT has encouraged many companies in the manufacturing sector to make use of this technology to unlock its potential. Pharmaceutical manufacturing companies are no exception to this, as IoT has the potential to revolutionize aspects of the pharmaceutical manufacturing process, from drug discovery to manufacturing. Using clear, concise language and real world case studies, this book discusses systems level from both a human-factors point-of-view and the perspective of networking, databases, privacy and anti-spoofing. The wide variety of topics presented offers readers multiple perspectives on a how to integrate the Internet of Things into pharmaceutical manufacturing. - Covers efficiency improvements of pharmaceutical manufacturing through IoT/Big Data approaches - Explores cutting-edge technologies through sensor enabled environment in the pharmaceutical industry - Discusses the systems level from both a human-factors point-of-view and the perspective of networking, databases, privacy and anti-spoofing
Publisher: Academic Press
ISBN: 0128203668
Category : Medical
Languages : en
Pages : 356
Book Description
Emergence of Pharmaceutical Industry Growth with Industrial IoT Approach uses an innovative approach to explore how the Internet of Things (IoT) and big data can improve approaches, create efficiencies and make discoveries. Rapid growth of the IoT has encouraged many companies in the manufacturing sector to make use of this technology to unlock its potential. Pharmaceutical manufacturing companies are no exception to this, as IoT has the potential to revolutionize aspects of the pharmaceutical manufacturing process, from drug discovery to manufacturing. Using clear, concise language and real world case studies, this book discusses systems level from both a human-factors point-of-view and the perspective of networking, databases, privacy and anti-spoofing. The wide variety of topics presented offers readers multiple perspectives on a how to integrate the Internet of Things into pharmaceutical manufacturing. - Covers efficiency improvements of pharmaceutical manufacturing through IoT/Big Data approaches - Explores cutting-edge technologies through sensor enabled environment in the pharmaceutical industry - Discusses the systems level from both a human-factors point-of-view and the perspective of networking, databases, privacy and anti-spoofing
Industry 4.0 Vision for the Supply of Energy and Materials
Author: Mahdi Sharifzadeh
Publisher: John Wiley & Sons
ISBN: 1119695953
Category : Technology & Engineering
Languages : en
Pages : 400
Book Description
Industry 4.0 Vision for the Supply of Energy and Materials Explore the impact of Industry 4.0 technologies on the supply chain with this authoritative text written by a leader in his field In Industry 4.0 Vision for the Supply of Energy and Materials, distinguished researcher and editor, Dr. Mahdi Sharifzadeh, delivers thematic, analytic, and applied discussions of the Industry 4.0 vision for supply chain design and operation. The book compiles all current aspects and emerging notions of Industry 4.0 into clusters of “enablers” and “analytics” of Supply Chain 4.0. Their multifaceted and highly interconnected nature is discussed at length, as are their diverse range of applications. You will discover uses of these new technologies ranging from the supply of conventional energy networks to renewables, pharmaceuticals, and additive manufacturing. You will also learn about their implications for economic prosperity and environmental sustainability. For each sector, this book scrutinizes current industrial practice and discusses developing concepts. Finally, the book concludes with potential future research directions of interest to industry practitioners and academics alike. Readers will also benefit from the inclusion of: A thorough introduction to connectivity through wireless communications and remote sensors An exploration of blockchains and smart contracts, as well as robotics and automation and cloud computing Practical discussions of supply chain analytics, including big data, machine-learning, and artificial intelligence, as well as supply chain modeling, optimization, and control A concise treatment of Industry 4.0 applications in supply chain design and operation, including the circular economy and the power industry An analysis of the oil, gas, and petrochemical industry, the pharmaceutical industry, and additive manufacturing Perfect for PhD-level and Postdoctoral researchers and industrial researchers, Industry 4.0 Vision for the Supply of Energy and Materials will also earn a place in the libraries of working professionals with an interest in the quantitative analysis of Supply Chain 4.0 concepts and techniques.
Publisher: John Wiley & Sons
ISBN: 1119695953
Category : Technology & Engineering
Languages : en
Pages : 400
Book Description
Industry 4.0 Vision for the Supply of Energy and Materials Explore the impact of Industry 4.0 technologies on the supply chain with this authoritative text written by a leader in his field In Industry 4.0 Vision for the Supply of Energy and Materials, distinguished researcher and editor, Dr. Mahdi Sharifzadeh, delivers thematic, analytic, and applied discussions of the Industry 4.0 vision for supply chain design and operation. The book compiles all current aspects and emerging notions of Industry 4.0 into clusters of “enablers” and “analytics” of Supply Chain 4.0. Their multifaceted and highly interconnected nature is discussed at length, as are their diverse range of applications. You will discover uses of these new technologies ranging from the supply of conventional energy networks to renewables, pharmaceuticals, and additive manufacturing. You will also learn about their implications for economic prosperity and environmental sustainability. For each sector, this book scrutinizes current industrial practice and discusses developing concepts. Finally, the book concludes with potential future research directions of interest to industry practitioners and academics alike. Readers will also benefit from the inclusion of: A thorough introduction to connectivity through wireless communications and remote sensors An exploration of blockchains and smart contracts, as well as robotics and automation and cloud computing Practical discussions of supply chain analytics, including big data, machine-learning, and artificial intelligence, as well as supply chain modeling, optimization, and control A concise treatment of Industry 4.0 applications in supply chain design and operation, including the circular economy and the power industry An analysis of the oil, gas, and petrochemical industry, the pharmaceutical industry, and additive manufacturing Perfect for PhD-level and Postdoctoral researchers and industrial researchers, Industry 4.0 Vision for the Supply of Energy and Materials will also earn a place in the libraries of working professionals with an interest in the quantitative analysis of Supply Chain 4.0 concepts and techniques.